SBH
FOLD

Segall Bryant & Hamill’s Amicus Therapeutics FOLD Stock Holding History

Segall Bryant & Hamill’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-209,196
Closed -$2.42M – 755
2021
Q4 		$2.42M Buy
209,196
+9,731
+5% +$108K 0.02% 392
2021
Q3 		$1.9M Buy
199,465
+5,300
+3% +$54.2K 0.02% 468
2021
Q2 		$1.87M Buy
194,165
+11,248
+6% +$110K 0.02% 460
2021
Q1 		$1.81M Sell
182,917
-2,616
-1% -$40.5K 0.02% 484
2020
Q4 		$4.28M Sell
185,533
-3,453
-2% -$70.6K 0.05% 317
2020
Q3 		$2.67M Buy
188,986
+137,233
+265% +$2M 0.04% 354
2020
Q2 		$781K Buy
51,753
+1,583
+3% +$19.3K 0.01% 488
2020
Q1 		$463K Sell
50,170
-5,607
-10% -$53.3K 0.01% 607
2019
Q4 		$543K Sell
55,777
-4,133
-7% -$37.8K 0.01% 642
2019
Q3 		$480K Buy
59,910
+249
+0.4% +$2.7K 0.01% 656
2019
Q2 		$744K Buy
59,661
+247
+0.4% +$3.13K 0.01% 594
2019
Q1 		$808K Buy
59,414
+1,588
+3% +$19.4K 0.01% 578
2018
Q4 		$554K Buy
57,826
+15,801
+38% +$174K 0.01% 632
2018
Q3 		$508K Sell
42,025
-34
-0.1% -$475 0.01% 675
2018
Q2 		$657K Buy
+42,059
New +$636K 0.01% 619

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Segall Bryant & Hamill's FOLD Position: Q1 2022 in Review

Segall Bryant & Hamill sold out of Amicus Therapeutics (FOLD) in Q1 2022, closing a stake of 209,196 shares — an estimated $2.42M sold.

Segall Bryant & Hamill first reported a position in FOLD in Q2 2018 and held it in 15 quarters. The position peaked at $4.28M in Q4 2020. 217 funds tracked by Wall St. Rank hold FOLD as of Q1 2022.

  • Segall Bryant & Hamill reported no remaining Amicus Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Segall Bryant & Hamill sold 209,196 Amicus Therapeutics shares in Q1 2022, an estimated $2.42M.
  • Segall Bryant & Hamill first reported a position in Amicus Therapeutics in Q2 2018 and held it in 15 quarters.
  • Segall Bryant & Hamill's Amicus Therapeutics position peaked at $4.28M in Q4 2020.
  • 217 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2022.

Based on Segall Bryant & Hamill's 13F filing for Q1 2022, filed 13 May 2022.